4,4′-Bis(2-Bromoacetyl)biphenyl CAS 4072-67-7 Daclatasvir Dihydrochloride Waena Maʻemaʻe >98.0% (HPLC)
ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana nui o 4,4'-Bis (2-Bromoacetyl) biphenyl (CAS: 4072-67-7) me ke kūlana kiʻekiʻe.Hiki iā Ruifu Chemical ke hāʻawi aku i ka honua holoʻokoʻa, ke kumukūʻai hoʻokūkū, ka lawelawe maikaʻi loa, ka liʻiliʻi a me ka nui nui i loaʻa.Kūʻai 4,4'-Bis(2-Bromoacetyl)biphenyl,Please contact: alvin@ruifuchem.com
| Inoa Kimia | 4,4'-Bis(2-Bromoacetyl)biphenyl |
| Nā huaʻōlelo like | 4,4'-Bis(Bromoacetyl)biphenyl;1,1'-[1,1'-Biphenyl]-4,4'-diylbis[2-Bromoethan-1-one];ʻO ka haumia ʻo Daclatasvir 7 |
| Kūlana Kūʻai | Ma ke Kahua, Hana Hana Kūʻai |
| Helu CAS | 4072-67-7 |
| ʻĀpana Molekala | C16H12Br2O2 |
| Kaumaha Molecular | 396.07 g/mol |
| Lae hehee | 226.0~227.0 ℃ |
| ʻO ka mānoanoa | 1.622±0.06 g/cm3 |
| COA & MSDS | Loaʻa |
| Ke kumu | Shanghai, Kina |
| Māhele | Ka waena o Daclatasvir Dihydrochloride (CAS: 1009119-65-6) |
| Brand | Kemika Ruifu |
| Nā mea | Nā kikoʻī | Nā hualoaʻa |
| Ka nana aku | Paʻa | Paʻa |
| Maʻemaʻe / Kaʻina Hanana | >98.0% (HPLC) | 98.5% |
| Infrared Spectrum | Kūlike me ka Hoʻolālā | Hoʻokō |
| 1H NMR Spectrum | Kūlike me ka Hoʻolālā | Hoʻokō |
| Ka hopena | Ua hoʻāʻo ʻia ka huahana a hoʻokō me nā kikoʻī i hāʻawi ʻia | |
| Palapala noi | Ka waena o Daclatasvir Dihydrochloride (CAS: 1009119-65-6) | |
Pūʻolo:ʻO ka ʻōmole Fluorinated, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E hoʻopaʻa paʻa i ka pahu a mālama i loko o kahi hale kūʻai maloʻo a me ka makani maikaʻi mai nā mea like ʻole.E pale i ka malamalama a me ka wai.
Hoʻouna:Hāʻawi i ka honua ma ka lewa, e FedEx / DHL Express.Hāʻawi wikiwiki a hilinaʻi hoʻi.
Pehea e kūʻai ai?E ʻoluʻolu e kelepona maiDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 mau makahiki ʻike?Loaʻa iā mākou ma mua o 15 mau makahiki o ka ʻike i ka hana ʻana a me ka hoʻokuʻu ʻana aku i kahi ākea ākea o nā intermediates pharmaceutical kiʻekiʻe a i ʻole nā kemika maikaʻi.
Mākeke Nui?E kūʻai aku i ka mākeke kūloko, ʻAmelika ʻĀkau, ʻEulopa, India, Korea, Iapana, Australia, etc.
Nā pono?ʻO ke kūlana kiʻekiʻe, ke kumukūʻai kūpono, nā lawelawe ʻoihana a me ke kākoʻo ʻenehana, ka lawe wikiwiki ʻana.
ʻAno maikaʻiHōʻoiaʻiʻo?Pūnaehana hoʻomalu maikaʻi koʻikoʻi.ʻO nā lako ʻoihana no ka nānā ʻana ʻo NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Nā laʻana?Hāʻawi ka hapa nui o nā huahana i nā laʻana manuahi no ka loiloi maikaʻi, pono e uku ʻia ke kumukūʻai e nā mea kūʻai aku.
Hooia Hale Hana?Welina mai ka loiloi hale hana.E ʻoluʻolu e hoʻopaʻa manawa ma mua.
MOQ?ʻAʻohe MOQ.ʻAe ʻia ke kauoha liʻiliʻi.
Manawa Hoʻouna? Inā i loko o ka waihona, ʻekolu lā hoʻouna ʻia.
Kaʻahele?Ma ka Express (FedEx, DHL), ma ka Air, ma ke Kai.
Nā palapala?Ma hope o ka lawelawe kūʻai: COA, MOA, ROS, MSDS, etc.
Hoʻohui Kuʻuna?Hiki ke hāʻawi i nā lawelawe synthesis maʻamau e kūpono i kāu mau pono noiʻi.
Kūkākūkā uku?E hoʻouna mua ʻia ka invoice Proforma ma hope o ka hōʻoia ʻana o ke kauoha, hoʻopili ʻia kā mākou ʻike panakō.Uku e T/T (Telex Transfer), PayPal, Western Union, etc.
ʻO 4,4'-Bis(2-Bromoacetyl)biphenyl (CAS: 4072-67-7) kahi mea waena o Daclatasvir Dihydrochloride (CAS: 1009119-65-6).
ʻO Daclatasvir Dihydrochloride (Daklinza) he mea hoʻopale o ka maʻi hepa C (HCV) NS5A i pono i ka mālama ʻana i ka genotype 3 maʻi hepatitis C mau loa.
Ma Iulai 24, 2015, ua ʻae ka FDA i ka lāʻau hepatitis C mau loa (Bristol-Myers Squibb) no ke kūʻai aku.
ʻO ke kaʻina hana ʻae FDA o Daklinza (Bristol-Myers Squibb) ua hoʻololi a huli.Ua hōʻole ʻia e ka FDA, akā ua ʻae ʻia i ka waena o 2015.Ua ʻae ka FDA i ka hui pū ʻana o Daklinza a me Sofosbuvir no ka mālama ʻana i nā maʻi maʻi hepatitis C gene type 3.
ʻO kaʻoiaʻiʻo, ma mua o ka ʻae ʻia ʻana o ka FDA, ua ʻae ʻia ʻo Daklinza no ke kūʻai aku ma Iapana, ka European Union a me South Korea a me nā ʻāina ʻē aʻe.I ka makahiki 2014, ua ʻae ka ʻāpana olakino Iapana i ka noi ʻana iā Daklinza a me Asunaprevir (Sunvepra) no ka mālama ʻana i ka maʻi genotype 1.Ua ʻae pū ka European Union iā Daclatasvir e hoʻohana pū me nā lāʻau lapaʻau ʻē aʻe i ka mālama ʻana i nā genotypes HCV 1, 2, 3 a me 4 i ka makahiki 2014. ʻO Daclatasvir ka mea paʻakikī paʻakikī NS5A mua i ʻae ʻia e ka European Union (EU).Ke hoʻohana pū ʻia me nā lāʻau lapaʻau ʻē aʻe, ke hoʻohālikelike ʻia me ka hui ʻana o ka interferon a me ribavirin e lawe ana i 48 mau pule, ʻoi aku ka pōkole o ka mālama ʻana (12 mau pule a i ʻole 24 mau pule).
ʻAʻole ʻōlelo ʻia ʻo Daclathavir monotherapy, ʻo ka protocol mainstream o kēia manawa ka hui pū ʻana o Dacastavir + Sofosbuvir, ka mea i hōʻike ʻia e ka maikaʻi maikaʻi, SVR kiʻekiʻe, nā hopena ʻaoʻao liʻiliʻi a me ka pōkole o ka mālama ʻana ma mua o nā koho ʻē aʻe.
